Skip to main content
OpenTrials
Completed

NCT Number: NCT01836081

Respirophasic Carotid Artery Peak Velocity Variation as a Predictor of Fluid Responsiveness in Patients With Coronary Disease

The aim of this study is to investigate usefulness of the respirophasic variation in carotid artery peak flow velocity measured by Doppler ultrasound, which is noninvasive and easily accessible, as a predictor of fluid responsiveness in patients with coronary artery disease.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yonsei University College of Medicine

Seoul, 120-752, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients scheduled for elective isolated off-pump coronary artery bypass graft surgery

Exclusion criteria

  • cardiac rhythm other than sinus
  • congestive heart failure
  • left ventricular ejection fraction <35%
  • history of transient ischemic attack
  • pre-existing cerebrovascular disease and peripheral arterial occlusive disease
  • presence of carotid artery stenosis >50%

Treatment and study plan

volume expansion

Other

Other names: volume expansion with 6 mL/kg of 6% hydroxylethyl starch 130/0.4

Primary outcomes

  1. Predictive power of the respirophasic carotid flow peak velocity variation for the fluid responsiveness

    Time frame: Measurement of respirophasic carotid flow peak velocity variation before the volume expansion

    After induction of anesthesia, peak velocity of carotid artery blood flow is measured by the pulsed wave Doppler signal obtained from the left common carotid artery. Respirophasic variation of the peak velocity is defined as the difference between the maximum and the minimum values of peak velocity divided by the mean of the two values during one respiratory cycle. Fluid responder is defined as a patient whose stroke volume index is increased ≥15% after volume expansion. The receiver operating characteristic curve analysis to descriminiate fluid responder is performed.

Sponsors and collaborators

Lead sponsor

Yonsei University

Other

Registry information

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Apr 19, 2013
Registry last updated
Apr 19, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.